Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record presents details of the completed Phase 2 nemolizumab study in adolescents with atopic dermatitis, including eligibility, treatment, locations, outcomes, and results-related information. It also includes study history, a linked publication, and study documents.SummaryDifference69%

- Check15 days agoChange DetectedThe footer site revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1 in the page footer.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating the study record is inaccessible. Added elements include a basic 403 header and a site footer with a Home link and a revision note, reflecting an access/permissions change rather than updates to the study data.SummaryDifference21%

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.